COMPOSITION AND METHOD FOR INDUCING LUTEOLYSIS

An injectable sustained release composition comprising a prostaglandin, formulated to release the prostaglandin in a sustained manner, and a method of inducing luteolysis of a functional corpus luteum in an animal by the sustained administration of a prostaglandin such as PGF2α, preferably cloproste...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	TUCKER, Ian George, EMSLIE, Forbes Richard, WALKER, Greg, BHUSAL, Prabhat, MCDOUGALL, Scott
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	An injectable sustained release composition comprising a prostaglandin, formulated to release the prostaglandin in a sustained manner, and a method of inducing luteolysis of a functional corpus luteum in an animal by the sustained administration of a prostaglandin such as PGF2α, preferably cloprostenol. L'invention concerne une composition injectable à libération prolongée comprenant une prostaglandine, formulée pour libérer la prostaglandine de manière prolongée, et une méthode d'induction de la lutéolyse d'un corps luteum fonctionnel chez un animal par l'administration prolongée d'une prostaglandine telle que PGF2α, de préférence la cloprosténol.